Many construction contracts contain some version of a “differing site conditions” clause. AIA’s A201 general conditions, as well as in the EJCDC equivalent, contains a changed site.
THOUSAND OAKS (dpa-AFX) - The U.S. Supreme Court ruled against Amgen (AMGN) in a long-running patent battle with Sanofi (SNY) and Regeneron Pharmaceuticals (REGN) over cholesterol drug, Repatha.The
/PRNewswire/ Sanofi (NASDAQ: SNY) is pleased with the United States Supreme Court s ruling in Amgen v. Sanofi et. al. The decision unanimously affirms the.